Abstract A 27 year old man with intestinal pseudoobstruction who developed parenteral nutrition induced hyperlipidaemia and who also had ophthalmoplegia and an undifferentiated myopathy is described. Histological examination of biopsy specimens and molecular analysis show that this patient had both familial visceral myopathy and a mitochondrial myopathy, suggesting that a mitochondrial DNA mutation is the molecular lesion in familial visceral myopathy.
The familial visceral myopathy syndromes are a clinically heterogeneous group of rare disorders of unknown molecular origin. Segregation patterns consistent with both autosomal dominant and autosomal recessive inheritance have been described in affected kindreds. ' The hallmark of the syndromes is the histological intestinal abnormality characterised by smooth muscle cell vacuolar degeneration, loss, and fibrosis, especially of the outer longitudinal muscle layer. 2 The mitochondrial myopathies encompass a distinct group of well described neurological syndromes (Kearns-Sayre, myoclonic epilepsy lactic acidosis and stroke-like syndromes (MELAS), myoclonic epilepsy and ragged red fibres (MERRF), and Leber's hereditary optic neuropathy) characterised histologically by the presence of coarse subsarcolemmal red staining aggregates in skeletal muscle, stained according to the modified Gomori trichrome method.3 Expression of these syndromes frequently reflects impaired mitochondrial function consequent to mitochondrial DNA (mtDNA) changes,4 most commonly deletions within the region spanning nucleotide bases 8000-9500.1 Because mitochondria are acquired from the ova, mitochondrial myopathies are generally maternally transmitted. 6 Individuals affected by either familial visceral myopathy7 or a mitochondrial myopathyt 9 manifest varying degrees of intestinal pseudoobstruction, polyneuropathy, leukoencephalopathy, lactic acidosis, and ophthalmoplegia. (BRL) and the oligonucleotide primers 5'-ACGAAAATCTGTTCGCTTCA-3' (spanning mtDNA nucleotides 8530-8550) and 5'-ATTGTGAAGATGATAAGTGT-3' (spanning mtDNA nucleotides 9090-9110). ' 
PATHOLOGY
The surgical duodenal specimen from the proband showed mild villous blunting and a slightly increased cellularity of the lamina propria. There was smooth muscle cell loss with fibrosis, especially within the outer longitudinal muscle layer (Fig 2A) . The myenteric plexus was unremarkable, containing numerous and normal ganglion cells. Electron microscopy examination confirmed myocyte loss and the presence of collagen fibrosis (Fig 2B) . In clinical terms, these histological findings established a diagnosis of familial visceral myopathy.
The gracilis muscle biopsy showed scattered degenerating and regenerating fibres with no inflammation, fibrosis, or neurogenic changes.
The Gomori trichrome stained sections showed subsarcolemmal aggregates of red granular material corresponding to abnormal mitochondria (not shown). Electron microscopy showed aggregates of mitochondria with intramitochondrial inclusions consisting of closely apposed parallel membranes resembling 'zippers' or 'parking lots' (Fig 3) . These skeletal muscle fibre changes were considered pathognomonic of a mitochondrial myopathy.
MOLECULAR ANALYSES
Southern blot analysis of BamHI, EcoRI, and HindlIl digested muscle DNA from our patient, hybridised with a labelled mtDNA probe, showed fragments of predicted size when compared with a normal control (Fig 4) . No heterogeneity of mtDNA species (heteroplasmy) was found.
The nucleotide sequence of the mtDNA domain 8530-9110 nucleotides (a region that encodes subunit 6 of ATPase) from the proband was identical to the wild type sequence, except for a single base substitution of a thymidine for cytosine at position 8634 (Fig 5) . This substitution was silent at the protein level: a tyrosine residue was translated both from the patient and the wild type mtDNA.
Discussion
We present a patient with the concomitant diagnoses of familial visceral myopathy and a mitochondrial myopathy. The diagnosis of familial visceral myopathy was based on characteristic clinical features and histological abnormalities within the small bowel. The diagnosis of a mitochondrial myopathy was based on the pathognomonic findings within the mitochondria of skeletal muscle cells when examined by Gomori trichrome and electron microscopy. The findings in this patient suggest that familial visceral myopathy and mitochondrial myopathies may have a similar molecular origin and could represent two points on the spectrum of a single disease.
Familial visceral myopathy and the mitochondrial myopathies have been distinguished from each other on the basis of muscle type affected. Familial visceral myopathy has been associated with smooth muscle cell abnormalities, whereas the mitochondrial myopathies have been characterised by skeletal muscle cell abnormalities. None of the reported cases of familial visceral myopathy, however, have undergone a Gomori trichrome stained muscle biopsy.' 27 5-22 Likewise, none of the reported cases of mitochondrial myopathies, specifically those in which patients were predominantly affected with a chronic intestinal pseudoobstruction, have reported the histological findings of the small bowel wall.9 It is thus possible that the failure to detect coexistent abnormalities in these conditions is the result of a lack of specific histological examination.
There are similarities in the expression of the clinical phenotypes of familial visceral myopathy and of the mitochondrial myopathies. For example, intestinal diverticulosis is a characteristic accompaniment of familial visceral myopathy and has also been described in the mitochondrial myopathies.9 Furthermore, extraintestinal neurological manifestations in familial visceral myopathy include ophthalmoplegia, megacystis, dementia, and seizure disorders,2 192022 features that are also characteristic of mitochondrial disorders. In addition, a patient with familial visceral myopathy had lactic acidosis, total parenteral nutrition induced hyperlipidaemia, right bundle branch block, polyneuropathy, and leukoencephalopathy,7 features that are characteristic of mitochondrial disorders. Our patient had many of these clinical features.
A factor that could theoretically distinguish between familial visceral myopathy and the mitochondrial myopathies is their mode of inheritance. Familial visceral myopathy is inherited as an autosomal trait,' whereas the mitochondrial myopathies classically display a maternal inheritance. Our patient had an affected male sibling and two female siblings who had both died in infancy, suggesting autosomal dominant inheritance with variable penetrance. This would be compatible with familial visceral myopathy but not with the classical mitochondrial myopathies. However, three pedigrees with mitochondrial myopathies have been reported in which defective paternal genes affecting nuclear control over mtDNA replication resulted in large scale mtDNA deletions.'4 Another study has shown paternal transmission of mtDNA from males in backcrossed mice.2 Thus, the mode of transmission does not necessarily distinguish familial visceral myopathy from a mitochondrial myopathy.
The genetic defect in familial visceral myopathy is unknown. In contrast, 40% of patients with mitochondrial myopathies have large scale deletions in muscle mtDNA usually including the region between nucleotides 8000 and 9500. In addition, one form of MERRF and one form of Leber's hereditary optic neuropathy are caused by point mutations within the mitochondrial genome.'6 Our patient had no gross structural changes of the muscle mtDNA genome. Furthermore, detailed sequence analysis of our patient's muscle mtDNA between nucleotides 8530 and 9110, a region that is often affected in mitochondrial myopathies, showed only a silent DNA polymorphism. The molecular defect in our patient remains to be determined. It is still possible that a single lesion affecting the mtDNA genome is responsible. The 
